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ABSTRACT DNA from the human neuroblastoma cell line
SK-N-SH is capable of inducing foci oftransformed NIH 3T3 cells
after DNA-mediated gene transfer. Using genetic selection with
the Escherichia coli sup Fgene, we have isolated human sequences
from mouse cells responsible for the oncogenic transformation.
These sequences are present in all human DNAs surveyed and no
gross rearrangements of these sequences are found in SK-N-SH
cells. Although clearly distinct from two other human transform-
ing genes present in bladder, lung, and colon carcinoma cell lines,
all three transforming gene sequences may be related members
of the ras gene family.
Several types of experiments have indicated the existence of
oncogenes of cellular origin. One set, the oncogenes present
in the rapidly transforming retroviruses (the v-onc genes), has
been detected by their homology to cellular genes (1-6). These
cellular genes (c-onc) presumably have normal physiological
functions when residing unperturbed in -their usual chromo-
somal setting. Another set of oncogenes, or cellular transform-
ing genes, has been detected in the DNA of tumors and tu-
morigenic cell lines by their ability to-induce foci oftransformed
cells after DNA-mediated gene transfer into NIH 3T3, a normal
growth-controlled mouse fibroblast cell line (7-11). These
transforming genes presumably arise from normal cellular genes
by mutation (12-14). Several different human transforming
genes have been reported and recently the transforming gene
of a human bladder carcinoma cell line has been isolated by
molecular cloning (12-14). We report here the isolation and
preliminary characterization ofanother transforming gene, that
present in the human neuroblastoma cell line SK-N-SH.
MATERIALS AND METHODS
Animal Cells. NIH 3T3 cells (15) were obtained from R.
Weinberg and co-workers (7) in 1978. These cells have under-
gone several subclonings in our laboratory since that time to
reduce spontaneous transformation. They are maintained at low
cell densities in Dulbecco's medium containing antibiotics
(streptomycin at 50 ,ug/ml and penicillin at 50 units/ml) and
10% calf serum (Flow Laboratories). Human tumor cell lines
used, which have been described (10), were: neuroblastomas,
SK-N-SH and IMR-32; lung carcinomas, SK-LU-1 and Calu-1;
colon carcinoma, SK-CO-1; hepatoma, SK-HEP-1; and bladder
carcinoma, T24. GM 2998 and XPVA-Het are low-passage hu-
man fibroblast lines and were provided by L. Grossman. PR371
is a human lung tumor that has been maintained in nude mice
and was provided by J. Fogh. The various NIH 3T3 transfor-
mants are described below.
Preparation of DNA, Hybridization, and Restriction En-
donuclease Digestion. High molecular weight DNA was pre-
pared from animal cells as described (10). DNA was prepared
from A phage Charon 4A and its derivatives by phage banding
in CsCl followed by phenol extraction (16). Plasmid DNA was
prepared from chloramphenicol-amplified cultures by deter-
gent lysis (17). DNA restriction endonuclease fragments were
purified by agarose gel electrophoresis and extracted from the
agarose by the KI/glass powder method (18). Agarose gel elec-
trophoresis and Southern blotting were carried out as described
(19). 32P-Labeled probes were prepared by nick-translation (20)
and blot hybridization was carried out at 71TC in 0.90 M NaCl/
0.09 M Nacitrate, pH 7.0. The final blotwash was 75mM NaCl/
7.5 mM Na citrate, pH 7.0 at 71TC. Restriction endonuclease
digestions were in buffers recommended by vendors (New En-
gland BioLabs, Bethesda Research Laboratories) and restriction
endonuclease mapping was done by analysis ofdouble digestion
products.
The bacterial plasmids used were blur 8 and pK5. Blur 8 con-
tains a 300-base-pair BamHI insert in pBR322 that is a member
of the human Alu family repeat (21) and was provided by W.
Jelinek. pK5 is apBR322 derivative containing the sup F gene.
Its complete restriction map will be published in another paper.
The sup F gene was originally -provided by I. Kudo and U.
RajRhandary.
Suppressor Rescue. DNA from NP-1, an NIH 3T3 transfor-
mant derived from SK-N-SH DNA (see Fig. 1), was partially
digested with EcoRI (0.1 unit ofenzyme per A±g ofDNA) at 37°C
for 30 min; 150 ,ug of DNA was loaded onto 10-40% sucrose
gradients in 100 mM NaCl/50 mM Tris-HCl/10 mM EDTA,
pH 8.0, and centrifuged at 24,000 rpm in a SW27 rotor for 24
hr at 20°C. Gradients were fractionated, and the 12- to 30-kilo-
base-.pair (kbp) fractions were pooled and ethanol precipitated.
DNA was dissolved, mixed (1:1, mol/mol) with a 1.5-kbp
EcoRI-cleaved sup F-containing fragment from pK5 (see above),
ligated at 100 pg/ml with T4 DNA ligase (Bethesda Research
Laboratories) in the buffer recommended by vendor. Ligated
DNA was mixed (1:3) with NIH 3T3 carrier DNA and used to
transfect NIH 3T3 cells by a modification of the calcium phos-
phate method (22) as described (10). Transformed foci were
picked after 3 wk and expanded for analysis. DNAwas prepared
from NIH 3T3 transformants containing sup F, partially di-
gested with EcoRI, and size fractionated as described above.
DNA in the 15- to 25-kbp range was mixed (1:1, mol/mol) with
EcoRI "arms" of Charon 4A and ligated as described above.
Ligated product was packaged into phage particles (23) and ti-
tered on the sup E sup F E. coli strain BNN45. To select sup
F-containing phage derivatives, 106 packaged phage were
plated onto a suppressor-free E. coli host strain, KS624. Phage
yieldingplaques on KS624 were picked and tested for the pres-
Abbreviation: kbp, kilobase pair(s).
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ence of suppressor by plating on alac Zar strain, JG139, in the
presence of the /3-galactoside indicator dye X-gal (5-bromo-4-
chloro-3-indoyl jD-galactoside) (24). Phage containing the sup
F gave blue plaques and were picked and expanded for further
analysis. A detailed description ofthese techniques will'be given
in another paper.
RecombinantDNA experiments were conducted under EKi!,
P2 containment. conditions as specified by the National Insti-
tutes of Health guidelines.
RESULTS
Molecular Cloning ofSequences with Transforming Activity
from Transformed Cells. DNA from SK-N-SH, a cell line de-
rived from a human neuroblastoma, can efficiently transform
NIH 3T3 cells (10). DNA from the NIH 3T3'transformants can
in turn transform fresh NIH 3T3cells, due to the serial passage
of a transforming-principle.by DNA-mediated gene transfer. To
isolate this transforming principle, we began with DNA from
a line ofNIH 3T3 cells transformed with DNA from SK-N-SH,
NP-1, that had a higher specific activity of transformation than
DNA from SK-N-SH itself.
We used the same strategy for gene isolation that we had used
in isolating the transforming gene of the human bladder car-
cinoma cell line T24 (12). This method (suppressor rescue),
which has been described briefly (12) and will be described in
greater detail in another paper, entails ligating restriction en-
donuclease-digested DNA from NP-i to a restriction endonu-
clease fragment containing a bacterial tRNA amber suppressor
gene (sup F). Because the transforming activity of NP-i DNA
was sensitive to cleavage with.EcoRI, BamHI, and HindIII (10),
we partially digested NP-L DNA with EcoRI and then ligated
size-fractionated.DNA to a 1.5-kbp EcoRI fragment containing
sup F. The ligated DNA was used to transform NIH 3T3 cells
and DNA from the resulting transformants was used in a second
round ofgene transfer to yield cells containing only a single copy
of sup F flanking the transforming gene. We used DNA from
these transformants to construct EcoRI partial libraries in the
bacteriophage- A vector Charon 4A, which contains two amber
mutations. Only those phage that have undergone mutation at
their amber loci or contain sup F-can grow, in a suppressor-free
bacterial host. We selected~in this way several phages that con-
tained sup F and flanking DNA from. the NIH 3T3 transfor-
mants. The lineage of four of these phages and the NIH 3T3
transformants used is shown in Fig. 1.
DNA was prepared from all four Akphages and analyzed by
EcoRI digestion. In addition to the Charon 4A arms, all phage
DNA had a 1.5-kbp EcoRI fragment containing sup F (see Fig.
2). Also, all four contained a common 7.0-kbp EcoRI fragment
and two phage, A NPS-1-i-1 and A NPS-1-1-2, derived from
NPS-i-i, contained a common 5.8-kbp EcoRI fragment. DNA
from all four phages were assayed for transforming activity on
NIH 3T3 cells. Only DNA from two phages, A NPS-1-1-1 and
A NPS-1-1-2, were active. They had a specific activity of trans-
formation (about 103 foci per pg'of phage.DNA) equal to that
of DNA from phage containing the transforming gene of the
bladder carcinoma cell line T24. These results suggested that
we had obtained a biologically active clone of the transforming
sequences of SK-N-SH.
Use of Transforming Sequences as Hybridization Probes.
Restriction endonuclease sites in A NPS-i-i-i DNA were
mapped, and the presence and positions of human or mouse
repeated sequences in this DNA were determined (Figs. 2 and
3). DNA digests were electrophoresed in agarose gels, blotted
onto nitrocellulose filters, and hybridized with32P-labeled nick-
translated total human DNA or total mouse DNA. A NPS-1-1-
SK-N-SH
NP-l NP-2] 1NP-31
SUPF - -. NP-1-1i FNjI21 N NP-2-2 NP-3-1
FIG. 1. Lineage of transformants and phage derivatives. DNA
from the human cell line SK-N-SH was used to induce foci of trans-
formed NIH 3T3 cells. Three foci were picked and expanded to yield
the primary transformants, NP-1, NP-2, and NP-3. DNAs from each
of these were then used toderive secondary transformants. In addition,
DNA from NP-1 was used to isolate the transforming sequences DNA
from NP-i was ligated to sup F DNA and the. ligAted DNA was used
to induce transformed foci. DNA from one of these, NPS-1, was used
to derive the additional transformed foci NPS-i- and NPS-1-2. From
these, we derived A phage containing sup F.-->, DNA transfection;
- -*, ligation and transfection; ---k, suppressor rescue.
1 and A NPS-1-1-2 sequences hybridized exclusively with hu-
man DNA (Fig. 2), consistent with an origin from the human
SK-N-SH cell line.
The structure of A NPS-1-1-1 DNA does not necessarily re-
flect the structure of-the transforming sequences as they occur
in SK-N-SH. Flanking sequences that-are not essential to gene
function are often lost during DNA-mediated gene transfer and.
linkage between previously unlinked sequences. is established
(25, 26). Nevertheless, we conclude that the transforming gene
of SK-N-SH is probably composed of two EcoRI fragments be-
cause (i) the transforming activity of SK-N-SH is destroyed by
EcoRI cleavage and (ii) two EcoRI fragments comprise-the en-
tire transforming sequence of A NPS-i-i-i. To investigate-the
structure ofthe transforminggene of SK-N-SHfturther, we used
two restriction fragments (denoted L and R in Fig. 3), one from
each EcoRI fragment, as probes in Southern -hybridizations.
Neither fragment L nor fragment R contain human repetitive
sequences and therefore they are good probes for unique se-
quence DNA.
In the first Southern hybridization experiment. (Fig. 4), frag-
ment R was used as a probe against. EcoRI-cleaved DNA from
NIH 3T3 (lane A), SK-N-SH (lane B)' one NIH 3T3 secondary
transformant from the human bladder carcinoma cell line T24
(lane L), one NIH'3T3 secondary transformant from the human
lung carcinoma cell line Calu-i (lane K), a series of-NIH 3T3
transformants- of various lineage but al ultimately derived by
transfection from SK-N-SH (lanes C-J), a series of human cell
lines (lanes P-Y), and human placenta (lane M). Fragment R
hybridized stronglyto a 9.2-kbp EcoRI fragment in SK-N-SH
DNA, to single fragments of various sizes in each NIH 3T3
transformant derived from SK-N-SH, and to single EcoRI frag-
ments in each of several human DNAs. These fragments co-
migrate with the 9.2-kbp fragment present in SK-N-SH. No
strong hybridization was seen in either NIH 3T3 cells or NIH
3T3 cells transformed with other human transforming genes.
In the second Southern hybridization experiment (Fig., 5),
a 1: 1 mixture offragments L and R.was used as probe to survey
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FIG. 2. Analysis of A phage containing sup F. DNA (0.2-1.0 ,ug) from the four phage A NPS-1-2-1 (lanes a), A NPS-1-1-2 (lanes b), A NPS-1-1-
3 (lanes c), and A NPS-1-1-1 (lanes d) was digested with EcoRI and electrophoresed in 1.0% agarose gels. Each phage is an independent isolate.(A) Ethidium bromide-stained gel. (B and C) DNA was denatured, transferred to nitrocellulose filters, and hybridized with total 32P-labeled nick-
translated human DNA (B) or mouse DNA (C). Digested DNAs contain in common 19.9- and 11.0-kbp A arms, a 1.5-kbp fragment containing sup
F, and a 7.0-kbp fragment hybridizing to repetitive human DNA. The 1.5-kbp fragment is not readily visible in lanes b and d, which contain less
DNA than lanes a and c. In addition, A NPS-1-1-1 (lanes d) and A NPS-1-1-2 (lanes b) contain a common 5.8-kbp fragment that hybridizes to repetitive
human DNA. A NPS-1-2-1 contains a 3.7-kbp fragment that hybridizes to repetitive mouse DNA. Arrowheads indicate the 19.9-, 11.0-, and 1.5-kbp
fragments.
the same DNAs. In this experiment, two EcoRI fragments ap-
peared in all human DNAs: the 9.2-kbp fragment observed pre-
viously and a 7.0-kbp fragment. Two EcoRI fragments were also
seen in most NIH 3T3 cells transformed with SK-N-SH DNA.
The apparent exceptions, NP-1 and NP-1-2 (lanes C and E),
contained two coincident EcoRI fragments that were separately
hybridizable to fragments L and R (data not shown). Again, no
strong hybridization was seen in either NIH 3T3 cells or NIH
3T3 cells transformed with other human transforming genes.
Taking these two experiments together, the results imply that
the transforming sequences ofSK-N-SH are contained in EcoRI
fragments of 9.2 and 7.0 kbp, that these transforming sequences
are human in origin, and that the transforming gene of SK-N-
SH is distinct from the transforming genes of T24 and SK-LU-
1 (10-12).
RI
SK-N-SH
We have inferred the restriction pattern of the chromosomal
transforming gene ofSK-N-SH (Fig. 3). We show that the gene
coincides with the sequences ofA NPS-1-1-1 from the left-most
EcoRI site to the left-most Bgl II site. We are confident of the
left-most EcoRI site because the left-most EcoRI/Xba 1 frag-
ment of A NPS-1-1-1 hybridizes to the same EcoRI DNA seg-
ments as does fragment L (data not shown) and of the Bgl II site
because Bgl II cleavage destroys the transforming activity of A
NPS-1-1-1 DNA (data not shown).
Distantly Related Sequences in Mice and Humans. When
fragment R was used as the probe in Southern blots, weakly
hybridizing EcoRI fragments were observed in all mouse and
human DNAs. In human DNAs, three EcoRI fragments, of ap-
proximate sizes 4.5, 10.5, and 15.0 kbp, were observed but only
a single weakly hybridizing fragment (7.0 kbp) was observed in
RI
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FIG. 3. Structure of the transforming sequences in SK-N-SH cells and A NPS-1-1-1. The restriction endonuclease sites of phage A NPS-1-1-1insert were mapped. EZ, Regions containing human Alu sequences as determined by blotting with plasmid blur 8; L and R, fragments used in
Southern hybridization experiments. The structure of the transforming sequences in SK-N-SH cells as inferred from the structure of A NPS-1-1-
1 and the hybridization experiments is also shown. RI, EcoRI; H, HindIII; Ba, BamHI; X, Xba I; K, Kpn I; Bg, Bgi II; S, Sma I.
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FIG. 4. Hybridization of transformant and humanDNAs with SK-N-SH transforming sequences (fragment R). Five-microgram samples ofDNA
(lanes: A, NIH 3T3; B, SK-N-SH; C, NP-1; D, NP-i-1; E, NP-1-2; F, NP-2; G, NP-2-1; H, NP-2-2; I, NP-3; J, NP-3-1; K, an NIH 3T3 secondary trans-
formant from Calu-1; L, an NIH 3T3 secondary transformant from T24; M, human placenta; P, SK-LU-1; Q, Calu-1; R, SK-CO-1; S, PR371; T, GM
2993; U, XPVA-Het; V, IMR-32; W, SK-N-SH; X, T24; Y, SK-HEP-1) were digested with EcoRI, electrophoresed in 1.0% agarose gels, and analyzed
by blot hybridization with 32P-labeled (3 x 108 cpm/,ug) fragment R (Fig. 3) as probe. Lanes N and 0 contain an EcoRI digest of a mixture of 120
pg of A NPS1-1-1 DNA and 5 gg of NIH 3T3 DNA carrier.
mouse DNA. We tentatively conclude from this that the R frag-
ment, which spans the Bgl II site disrupting transforming ac-
tivity, contains sequences that are conserved in evolution and
that a single mouse homolog of this human gene exists. In hu-
mans, as many as three additional homologous genes may exist.
Finally, we note that, in NIH 3T3 cells transformed with
DNA from the human lung carcinoma cell line Calu-i, an ad-
ditional weakly hybridizing EcoRI fragment, 3.6 kbp in size, is
observed. Curiously, a comigrating species is not detected by
hybridization in human DNA. We therefore examined two ad-
ditional NIH 3T3 transformants for the presence of this band:
NIH 3T3 cells transformed with DNA from SK-LU-1, another
human lung carcinoma cell line, and NIH 3T3 cells transformed
with DNA from SK-CO-1, a human colon carcinoma cell line.
DNA from these transformants also contained a 3.6-kbp EcoRI
fragment that hybridized to fragment R (data not shown). Pre-
vious work has shown that SK-LU-1, SK-CO-1, and Calu-1 con-
tain a common transforming gene (10). We interpret this result
to mean that the transforming gene common to these three hu-
man carcinoma cell lines is distantly related to the transforming
gene ofSK-N-SH. We attribute our ability to observe this frag-
A B I D E G H I J K L M N
ment in transformants, but not in human DNA, to an amplifi-
cation of the transforming sequences in NIH 3T3 cells that
raises the hybridization signal above background levels. Al-
though other interpretations are possible, other work justifies
this conclusion (unpublished data).
DISCUSSION
Several human transforming genes have been identified by us-
ing DNA-mediated gene transfer and focus induction in NIH
3T3 cells as an assay. Transforming genes have been isolated by
molecular cloning from T24 (12, 14), ahuman bladder carcinoma
cell, and from EJ (13), another human bladder carcinoma cell.
The two genes appear to be identical to each other and also to
the transforming gene of yet a third human bladder carcinoma
cell line, J82 (27). However, all three cell lines used in those
studies were probably derived from a common cell line and rep-
resent only a single instance of activation of that gene (unpub-
lished data). A second human transforming gene has been iden-
tified that is common to a colon carcinoma cell line and several
other lung and colon carcinoma cell lines (10, 11). Several other
kbp
0 P 0 P S T U V W X Y
- 22 5
7 0 _OW
45
n~~~~~~~~~a
FIG. 5. Hybridization of transformant and human DNAs with SK-N-SH transforming sequences (fragments R and L). EcoRI-digested DNAs
are as in Fig. 4. In this experiment, a 1: 1 mixture of fragments R and L (Fig. 3) was 32P-labeled by nick-translation to 3 x 108 cpm/,ug and used
as the hybridization probe.
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distinct human transforming genes are associated with a breast
carcinoma cell line, MCF-7 (28), a leukemic cell line, HL60
(11), and a neuroblastoma cell line, SK-N-SH (10).
In this paper, we have reported the isolation by molecular
cloning of the transforming gene from SK-N-SH. Biologically
active transforming sequences were obtained by genetic selec-
tion. Hybridization studies showed that these sequences were
found in each NIH 3T3 cell transformed by SK-N-SH DNA.
Two EcoRI fragments, of approximate sizes 9.2 and 7.0 kbp,
comprise the gene and are found in every human cell line we
have examined. Thus, like the transforming gene of T24, the
transforming gene of SK-N-SH is likely to have arisen without
gross sequence rearrangement from a normal cellular gene.
The SK-N-SH transforming sequences hybridize to other
human sequences. In particular, a 1.0-kbp HindIII fragment
(fragment R) hybridizes to EcoRI fragments in human DNA of
sizes 4.5, 10.5, and 15.0 kbp. Thus, as many as three other hu-
man genes may be closely related to the SK-N-SH gene. In
addition, the 1.0-kbp HindIII fragment hybridizes, although
less strongly, to the human sequences present in NIH 3T3 cells
transformed with the common lung/colon carcinoma transform-
ing gene. Thus, the transforming gene ofSK-N-SH may belong
to a still larger gene family. Other work (unpublished) confirms
this conclusion and shows that this family contains at least three
distinct transforming genes: the transforming gene of SK-N-
SH, the transforming gene common to lung and colon carcinoma
cell lines, and the transforming gene present in the bladder
carcinoma cell line T24. Recent work also indicates that these
genes are related to Kirsten and Harvey ras genes (refs. 27 and
29; unpublished data), the oncogenes of Kirsten and Harvey
sarcoma viruses (30).
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